Yuzu (Citrus junos)

Citrus junos
Evidence Level
Preliminary
4 Clinical Trials
5 Documented Benefits
1/5 Evidence Score

Yuzu (Citrus junos), called yuja in Korea, is a sour, fragrant citrus fruit grown mainly in Japan and Korea. Its peel holds most of the fruit's flavanones, chiefly hesperidin and naringin, along with vitamin C, while the seeds contain bitter compounds called limonoids. Oral human research is very thin. One small crossover trial in adults with prediabetes found lower fasting glucose, fasting insulin and an insulin-resistance score after 8 weeks of a peel extract than after placebo, though not versus baseline, and it was published in a journal not indexed in PubMed. A Korean cholesterol trial and a small Japanese study of yuzu peel food for feeling cold were registered and completed but have no published results. Most other findings come from cells and mice. The well-known yuzu scent and bath studies tested inhaled fragrance, not supplements.

Studied Dose 4,250 mg a day of a yuzu peel ethanol extract for 8 weeks in the only published human trial. A registered 7-day Japanese study used 10 g a day of a processed yuzu peel food. Mouse studies used 1% to 5% of the diet or 100 mg/kg a day.
Active Compound Peel flavanones, mainly hesperidin and naringin (with neohesperidin), plus vitamin C; the seeds supply limonoids.

Benefits

Fasting blood sugar and insulin markers

In a crossover trial, 35 adults with prediabetes took a yuzu peel ethanol extract (4,250 mg a day) or placebo for 8 weeks each. Fasting glucose, fasting insulin and HOMA-IR, an insulin-resistance score, were lower after the extract than after placebo but not versus baseline, and post-meal glucose was not significantly improved. The journal is not indexed in PubMed.

Liver fat and blood cholesterol in mice

In mice on a high-cholesterol diet, 1% or 5% yuzu peel extract in the feed lowered body weight, liver fat, and total and LDL cholesterol, and in high-fat-fed mice 5% extract lowered serum triglycerides and cholesterol. These are animal findings. A 12-week placebo-controlled cholesterol trial in Korean adults was completed in 2017, but no results have been posted or published.

Body weight and body fat in high-fat-fed mice

In high-fat-fed mice, an extract of green (unripe) yuzu peel at 100 mg/kg a day reduced weight gain, body fat percentage and visceral fat, and 5% peel extract in the feed reduced weight gain in another mouse study. No published human trial has measured body weight or body fat with yuzu.

Platelet aggregation in lab and animal tests

A yuzu extract, hesperidin and naringin reduced clumping of human platelets in test tubes and of rat platelets in vitro and ex vivo, and oral yuzu extract prolonged bleeding time in mice. No human trial has tested this. The same effect is a reason for caution with blood thinners rather than a proven benefit.

Flavanone and vitamin C content of the fruit

Fresh yuzu averaged about 90 mg of vitamin C, 64 mg of naringin and 66 mg of hesperidin per 100 g, with more in the peel than the flesh, and hesperidin and naringin in the peel rose as the fruit ripened. Among three Korean citrus fruits, yuzu had the highest antioxidant activity and total phenolics in lab assays.

Mechanism of action

1

Glucose uptake through AMPK and PPAR-gamma

In C2C12 muscle cells, an ethanol extract of yuzu peel, but not of the pulp, raised glucose uptake and increased AMPK and PPAR-gamma activity; blocking AMPK reduced the effect. Muscle AMPK activation was also seen in high-fat-fed mice. These are cell and mouse findings.

2

Liver fat-burning and cholesterol-making genes

In HepG2 liver cells and in mice on a high-cholesterol diet, yuzu peel extract raised PPAR-alpha and CPT1, which drive fat burning, and lowered HMGCR, the rate-limiting enzyme in cholesterol production. These are cell and mouse findings.

3

Fat-cell formation signals

In 3T3-L1 cells, a green yuzu peel extract curbed the formation of fat cells by lowering PI3K-Akt signaling and the fat-making regulators PPAR-gamma, C/EBP-alpha and DGAT2. This is a cell finding.

4

Seed limonoids and inflammatory signals in cells

Limonoids isolated from yuzu seeds lowered inflammatory messengers such as IL-6, IL-8 and TNF-alpha in stimulated mouse immune cells and human colon cells. Whether supplements supply these compounds in useful amounts is unknown.

Clinical trials

1
Yuzu Peel Extract and Fasting Glucose: 8-Week Crossover RCT (not PubMed-indexed)
PubMed

Randomized, double-blind, placebo-controlled crossover trial of an ethanol extract of yuzu (yuja) peel, published in a journal not indexed in PubMed; participant numbers and dose are as tabulated in a 2021 review. (Hwang et al. 2015, J Funct Foods)

35 adults with prediabetes (impaired fasting glucose; the review classes them as combined impaired fasting glucose and impaired glucose tolerance); 4,250 mg a day of extract or placebo for 8 weeks per period.

The abstract reports significantly lower fasting glucose, fasting insulin and HOMA-IR after the extract than after placebo, with post-meal glucose and C-peptide only slightly reduced and no difference in safety measures. As reported by a 2021 review, the p values were 0.049, 0.038 and 0.019, none of the three changed significantly from baseline, C-peptide was marginally lower (p = 0.057), and no adverse events occurred. Funding is not stated in the abstract.

2
Yuzu Peel Extract and Blood Cholesterol: 12-Week RCT (registered, no results)
PubMed

Randomized, double-blind, placebo-controlled, parallel trial registered as NCT03332641 by Hanyang University, Seoul. (Hanyang University 2017, ClinicalTrials.gov)

Adults aged 19 to 75 with total cholesterol of 200 to 239 mg/dL, not on lipid-lowering drugs; the record lists 70 enrolled, though its description mentions twenty subjects. No dose is given.

The study is marked completed in September 2017, but no results have been posted and no publication is linked, so the effect on cholesterol is unknown.

3
Processed Yuzu Peel Food and Feeling Cold: 7-Day Open-Label Study (registered, no results)
PubMed

Single-arm, open-label, uncontrolled study registered as UMIN000051566 by Kochi University. (Kochi University 2023, UMIN Clinical Trials Registry)

9 healthy female students aged 20 to 24 who reported feeling cold; 10 g a day of a processed yuzu peel food for 7 days.

Primary outcomes were skin surface temperature, blood pressure, pulse and body temperature. The study is marked completed in 2023 with no results posted or published, and with no control group it could not separate any change from day-to-day variation.

4
Yuzu Peel Extract, Glucose Uptake and High-Fat-Fed Mice (cell and mouse study)
PubMed

Cell-culture and mouse feeding study comparing peel and pulp extracts of yuzu. (Kim et al. 2013, Evid Based Complement Alternat Med)

C2C12 mouse muscle cells and mice fed a high-fat diet with or without 5% yuzu peel ethanol extract.

Only the peel ethanol extract raised muscle-cell glucose uptake, through AMPK and PPAR-gamma. In mice it reduced weight gain, liver fat, serum triglycerides, total cholesterol and insulin resistance. These are animal and cell results, not evidence of effects in people.

Side effects and drug interactions

Common Potential side effects

No adverse events were reported in the 8-week crossover trial of 4,250 mg a day of yuzu peel extract, and safety measures did not differ from placebo; that is the only published human safety data for an oral extract.
Citrus allergy: a 12-year-old with cashew allergy had sore throat, nausea and severe abdominal pain after a jelly made with yuzu seeds and peel, and vomited during a later supervised challenge with a citrus seed jelly. People allergic to citrus or cashew should avoid yuzu products, especially those containing seeds.
Pregnancy, breastfeeding, children and use longer than 8 weeks have not been studied.
Products differ (peel extract, juice concentrate, seed oil), so the trial result applies only to a peel ethanol extract.

Important Drug interactions

Blood thinners and antiplatelet drugs: yuzu extract reduced platelet clumping in lab tests and prolonged bleeding time in mice. Human relevance is unknown; ask your doctor before combining.
Diabetes medicines: a yuzu peel extract lowered fasting glucose versus placebo in one small trial, so blood sugar should be monitored if you use both.
CYP3A drug metabolism: in a lab test, yuzu slices inhibited CYP3A only weakly (1/8 to 1/20 of grapefruit juice); concentrated extracts have not been tested.

Frequently asked questions about Yuzu (Citrus junos)

What is yuzu?

Yuzu (Citrus junos), or yuja in Korea, is a sour, aromatic citrus fruit from Japan and Korea. Its peel is rich in the flavanones hesperidin and naringin and in vitamin C; fresh fruit averaged about 66 mg hesperidin, 64 mg naringin and 90 mg vitamin C per 100 g in one analysis.

Is a yuzu supplement the same as hesperidin or nobiletin?

No. Yuzu peel extract contains hesperidin among many other compounds, so results for pure hesperidin do not transfer directly, and the published yuzu trial did not report a hesperidin dose. Nobiletin is a different citrus peel flavone with its own research; the yuzu studies cited here did not measure it.

Do yuzu scent and yuzu bath studies apply to capsules?

No. Studies such as one in 20 young women who inhaled yuzu scent for 10 minutes measured mood scores and a saliva stress marker after smelling the fragrance. They say nothing about swallowing yuzu extract, so they are not counted as evidence here.

How much yuzu extract has been studied?

The only published human trial used 4,250 mg a day of a yuzu peel ethanol extract for 8 weeks. A Korean cholesterol trial and a 7-day Japanese study of 10 g a day of processed peel food were completed but have no published results.

Is yuzu extract safe?

No adverse events were reported in the one 8-week trial, but that is very little data. People with citrus or cashew allergy, those taking blood thinners or diabetes medicines, and pregnant or breastfeeding women should talk to a doctor first.

What is Yuzu used for?

Yuzu is researched primarily for Metabolic Health. In a crossover trial, 35 adults with prediabetes took a yuzu peel ethanol extract (4,250 mg a day) or placebo for 8 weeks each.

What is the recommended dosage of Yuzu?

The clinically studied dose is 4,250 mg a day of a yuzu peel ethanol extract for 8 weeks in the only published human trial. A registered 7-day Japanese study used 10 g a day of a processed yuzu peel food. Mouse studies used 1% to 5% of the diet or 100 mg/kg a day. Always follow the product label and check with a healthcare provider for personal advice.

Is Yuzu safe, and does it have side effects?

Side effects and cautions reported for Yuzu include: No adverse events were reported in the 8-week crossover trial of 4,250 mg a day of yuzu peel extract, and safety measures did not differ from placebo; that is the only published human safety data for an oral extract. It may also interact with some medications. Yuzu is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Yuzu interact with any medications?

Possible interactions include: Blood thinners and antiplatelet drugs: yuzu extract reduced platelet clumping in lab tests and prolonged bleeding time in mice. Human relevance is unknown; ask your doctor before combining. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Yuzu?

NutraSmarts rates the evidence for Yuzu as Preliminary (1 out of 5). It is backed by 4 clinical trials and 15 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(15 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Hwang JT, Yang HJ, Ha KC, So BO, Choi EK, Chae SW. A randomized, double-blind, placebo-controlled clinical trial to investigate the anti-diabetic effect of Citrus junos Tanaka peel. J Funct Foods. 2015;18:532-537. doi: 10.1016/j.jff.2015.08.019.SourceUsed to support: Not PubMed-indexed (Journal of Functional Foods); abstract read, full text not read, and the abstract gives no participant number, dose or p values. Randomized, double-blind, placebo-controlled crossover trial of an ethanol extract of yuzu (yuja) peel in adults with impaired fasting glucose (prediabetes), with 8-week treatment periods. Fasting plasma glucose, fasting insulin and HOMA-IR were lower after the extract than after placebo; post-meal glucose and C-peptide fell only slightly, and safety measures did not differ between groups. A 2021 review tabulates the trial as 35 participants taking 4,250 mg a day, with significant changes versus placebo but not versus baseline and no adverse events.
  2. Lim WXJ, Gammon CS, von Hurst P, Chepulis L, Page RA. A Narrative Review of Human Clinical Trials on the Impact of Phenolic-Rich Plant Extracts on Prediabetes and Its Subgroups. Nutrients. 2021;13(11):3733. doi: 10.3390/nu13113733.PubMedUsed to support: Narrative review of human trials of phenolic-rich plant extracts in prediabetes. It summarizes the yuzu peel trial as a randomized crossover in 35 adults with combined impaired fasting glucose and impaired glucose tolerance taking 4,250 mg a day or placebo for 8 weeks: fasting glucose (p = 0.049), fasting insulin (p = 0.038) and HOMA-IR (p = 0.019) were lower than with placebo but not significantly changed from baseline, post-meal glucose did not change, C-peptide was marginally lower (p = 0.057), and no adverse events were reported. The authors conclude that evidence on plant extracts in prediabetes subgroups remains scarce.
  3. Hanyang University. Effect of Intake of Citron (Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol (NCT03332641). ClinicalTrials.gov. 2017;Registry record NCT03332641, accessed 2026..SourceUsed to support: Not PubMed-indexed (trial registry record). A 12-week, randomized, double-blind, placebo-controlled trial of yuzu (citron) peel extract on blood cholesterol in adults aged 19 to 75 with total cholesterol of 200 to 239 mg/dL, run at Hanyang University in Seoul from June to September 2017. The record lists 70 enrolled (its description mentions twenty subjects), gives no dose, is marked completed, and has no posted results or linked publication.
  4. Kochi University. Effects of Continuous Intake of Processed Yuzu Peel Foods on improving Cold Sensitivity (UMIN000051566). UMIN Clinical Trials Registry. 2023;Registry record UMIN000051566 (receipt R000058833), accessed 2026..SourceUsed to support: Not PubMed-indexed (trial registry record). A single-arm, open-label, uncontrolled study at Kochi University in healthy female students aged 20 to 24 who reported feeling cold: 10 g a day of a processed yuzu peel food for 7 days, with skin surface temperature, blood pressure, pulse and body temperature as primary outcomes. Nine people were enrolled and the study is marked completed in 2023, with no results posted or published.
  5. Kim SH, Hur HJ, Yang HJ, Kim HJ, Kim MJ, Park JH, Sung MJ, Kim MS, Kwon DY, Hwang JT. Citrus junos Tanaka Peel Extract Exerts Antidiabetic Effects via AMPK and PPAR-γ both In Vitro and In Vivo in Mice Fed a High-Fat Diet. Evid Based Complement Alternat Med. 2013;2013:921012. doi: 10.1155/2013/921012.PubMedUsed to support: Cell and mouse study: only the ethanol extract of yuzu peel, not pulp or water extracts, raised glucose uptake in C2C12 muscle cells, and it increased PPAR-gamma and AMPK activity; an AMPK inhibitor reduced the effect. In high-fat-fed mice, 5% peel extract in the diet reduced weight gain, liver fat, serum triglycerides, total cholesterol, insulin resistance, leptin and resistin. Cell and animal evidence only.
  6. Shin EJ, Park JH, Sung MJ, Chung MY, Hwang JT. Citrus junos Tanaka peel ameliorates hepatic lipid accumulation in HepG2 cells and in mice fed a high-cholesterol diet. BMC Complement Altern Med. 2016;16(1):499. doi: 10.1186/s12906-016-1460-y.PubMedUsed to support: Cell and mouse study: a 70% ethanol extract of yuzu peel reduced fat build-up in HepG2 liver cells, raising AMPK, ACC, PPAR-alpha and CPT1 and lowering HMGCR. In mice on a high-cholesterol diet (8 per group), 1% or 5% extract in the diet reduced body weight, liver fat, liver weight, and total and LDL cholesterol versus the high-cholesterol diet alone. Cell and animal evidence only.
  7. Heo YJ, Lee MK, Im JH, Kim BS, Lee HI. Anti-obesity effects of ethanol extract of green Citrus junos peel enriched in naringin and hesperidin in vitro and in vivo. Nutr Res Pract. 2025;19(1):1-13. doi: 10.4162/nrp.2025.19.1.1.PubMedUsed to support: Cell and mouse study: the authors note that green (unripe) yuzu peel has more naringin and hesperidin than yellow peel. Its ethanol extract curbed fat-cell formation in 3T3-L1 cells, lowering C/EBP-alpha, PPAR-gamma, DGAT2 and PI3K-Akt signaling. In high-fat-diet obese mice, 100 mg/kg a day reduced body weight, weight gain, serum lipids, body fat percentage and visceral fat. Cell and animal evidence only.
  8. Yu HY, Park SW, Chung IM, Jung YS. Anti-platelet effects of yuzu extract and its component. Food Chem Toxicol. 2011;49(12):3018-24. doi: 10.1016/j.fct.2011.09.038.PubMedUsed to support: Animal and lab study: a methanol extract of yuzu and its component hesperidin inhibited rat platelet aggregation in vitro and ex vivo, naringin inhibited aggregation for all agonists except ADP, and oral yuzu extract or hesperidin prolonged tail bleeding time in mice in a dose-dependent way. No human data.
  9. Kim TH, Kim HM, Park SW, Jung YS. Inhibitory effects of yuzu and its components on human platelet aggregation. Biomol Ther (Seoul). 2015;23(2):149-55. doi: 10.4062/biomolther.2015.011.PubMedUsed to support: Lab study: an ethanol extract of yuzu, hesperidin and naringin inhibited aggregation of human platelets in platelet-rich plasma in a concentration-dependent way, reducing thromboxane B2 formation and ADP release. The paper also reports ex vivo rat platelet and mouse tail-bleeding tests. No one took yuzu by mouth in this study.
  10. Yoo KM, Lee KW, Park JB, Lee HJ, Hwang IK. Variation in major antioxidants and total antioxidant activity of Yuzu (Citrus junos Sieb ex Tanaka) during maturation and between cultivars. J Agric Food Chem. 2004;52(19):5907-13. doi: 10.1021/jf0498158.PubMedUsed to support: Composition study: yuzu peel had more phenolics, vitamin C and antioxidant activity than the flesh, and hesperidin and naringin in the peel rose with ripening. Mean contents per 100 g of fresh yuzu were 90.4 mg vitamin C, 63.8 mg naringin and 65.7 mg hesperidin, and vitamin C accounted for most of the measured antioxidant activity.
  11. Yoo KM, Hwang IK, Park JH, Moon B. Major phytochemical composition of 3 native Korean citrus varieties and bioactive activity on V79-4 cells induced by oxidative stress. J Food Sci. 2009;74(6):C462-8. doi: 10.1111/j.1750-3841.2009.01229.x.PubMedUsed to support: Composition and cell study of three Korean citrus fruits, including yuzu (yuza): naringin, hesperidin and neohesperidin were the main flavonoids, and yuzu had the highest antioxidant activity, total phenolics and carotenoids of the three in lab assays. Lab evidence only.
  12. Shin J, Song HY, Lee M. Sudachinoid- and Ichangensin-Type Limonoids from Citrus junos Downregulate Pro-Inflammatory Cytokines. Int J Mol Sci. 2020;21(18):6963. doi: 10.3390/ijms21186963.PubMedUsed to support: Cell study: 13 limonoids isolated from yuzu seeds, including a new compound, lowered IL-1beta, IL-6, IL-8, TNF-alpha and NF-kappaB in stimulated mouse macrophages and human colon cells; sudachinoid- and ichangensin-type limonoids were more potent than nomilin and limonin. Cell evidence only.
  13. Ishihara M, Toda H, Sunagane N, Ohta T. [Furanocoumarins contents and cytochrome P450 3A (CYP3A) inhibitory activities of various processed fruit peel products: outflow of 6',7'-Dihydroxybergamottin during processing treatment of peel]. Yakugaku Zasshi. 2011;131(5):679-84. doi: 10.1248/yakushi.131.679.PubMedUsed to support: Lab study (Japanese-language article) of processed citrus peel products: grapefruit, lemon and bitter orange peel products inhibited the drug-metabolizing enzyme CYP3A about as much as grapefruit juice, while yuzu slices were very weak inhibitors, at 1/8 to 1/20 of grapefruit juice. Furanocoumarin content tracked CYP3A inhibition (r = 0.78). Yuzu extracts and supplements were not tested.
  14. Itabashi K, Makita E, Kuroda S, Sugawara D, Hayashi K, Ohkubo M, Hirakubo Y, Nonaka K, Yamane H. [A CASE OF CASHEW NUT-RELATED CITRUS SEED ALLERGY WITH SUSPECTED CITRIN INVOLVEMENT]. Arerugi. 2024;73(9):1163-1167. doi: 10.15036/arerugi.73.1163.PubMedUsed to support: Case report (Japanese-language article): a 12-year-old girl with cashew nut allergy had sore throat, nausea and severe abdominal pain after a jelly made with yuzu seeds and peel. Skin tests were positive for yuzu seeds and lemon seeds, and an oral food challenge with jelly containing whole citron and lemon seeds caused abdominal pain and vomiting. The authors diagnosed a cashew-related citrus seed allergy.
  15. Matsumoto T, Asakura H, Hayashi T. Effects of olfactory stimulation from the fragrance of the Japanese citrus fruit yuzu (Citrus junos Sieb. ex Tanaka) on mood states and salivary chromogranin A as an endocrinologic stress marker. J Altern Complement Med. 2014;20(6):500-6. doi: 10.1089/acm.2013.0425.PubMedUsed to support: Randomized crossover study in 20 healthy young women: 10 minutes of inhaling yuzu scent, versus unscented water, lowered salivary chromogranin A and mood-disturbance scores for up to 30 minutes. This tested inhaled fragrance, not oral intake, so it does not show effects of yuzu supplements.